INS and diabetes mellitus: Another important finding in our study is that the cut-off (≤0.20 nmol/mmol) for a differential diagnosis of diabetes is also helpful in identifying patients who need insulin or secretagogue therapy added to their treatment regimen to achieve their goal of glucose control.